{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:15:31Z","timestamp":1780046131874,"version":"3.53.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00134-026-08437-y","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:36:26Z","timestamp":1777268186000},"page":"784-787","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Restrictive nutrition in shock: reassuring renal signals\u2014but no proof of safety"],"prefix":"10.1007","volume":"52","author":[{"given":"Silvia","family":"De Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-0881","authenticated-orcid":false,"given":"Michael","family":"Joannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"8437_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1164\/rccm.201505-0995OC","volume":"193","author":"JA Kellum","year":"2016","unstructured":"Kellum JA, Chawla LS, Keener C, Singbartl K, Palevsky PM, Pike FL et al (2016) The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med 193:281\u2013287. https:\/\/doi.org\/10.1164\/rccm.201505-0995OC","journal-title":"Am J Respir Crit Care Med"},{"key":"8437_CR2","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120:c179-184. https:\/\/doi.org\/10.1159\/000339789","journal-title":"Nephron Clin Pract"},{"key":"8437_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","volume":"13","author":"LS Chawla","year":"2017","unstructured":"Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM et al (2017) Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 13:241\u2013257. https:\/\/doi.org\/10.1038\/nrneph.2017.2","journal-title":"Nat Rev Nephrol"},{"key":"8437_CR4","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S2213-2600(23)00092-9","volume":"11","author":"J Reignier","year":"2023","unstructured":"Reignier J, Plantefeve G, Mira J-P, Argaud L, Asfar P, Aissaoui N et al (2023) Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3). Lancet Respir Med 11:602\u2013612. https:\/\/doi.org\/10.1016\/S2213-2600(23)00092-9","journal-title":"Lancet Respir Med"},{"key":"8437_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-026-08369-7","author":"M Schleef","year":"2026","unstructured":"Schleef M, Mayet V, Le Gouge A et al (2026) Low versus standard calorie and protein feeding and renal dysfunction in ventilated adults with shock: a NUTRIREA-3 post-hoc analysis. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-026-08369-7","journal-title":"Intensive Care Med"},{"key":"8437_CR6","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00134-015-3827-9","volume":"41","author":"GS Doig","year":"2015","unstructured":"Doig GS, Simpson F, Bellomo R, Heighes PT, Sweetman EA, Chesher D et al (2015) Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial. Intensive Care Med 41:1197\u20131208. https:\/\/doi.org\/10.1007\/s00134-015-3827-9","journal-title":"Intensive Care Med"},{"key":"8437_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2403769","volume":"391","author":"G Landoni","year":"2024","unstructured":"Landoni G, Monaco F, Ti LK, BaiardoRedaelli M, Bradic N, Comis M et al (2024) A randomized trial of intravenous amino acids for kidney protection. N Engl J Med 391:687\u2013698. https:\/\/doi.org\/10.1056\/NEJMoa2403769","journal-title":"N Engl J Med"},{"key":"8437_CR8","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.jtcvs.2018.11.097","volume":"157","author":"H Pu","year":"2019","unstructured":"Pu H, Doig GS, Heighes PT, Allingstrup MJ, Wang A, Brereton J et al (2019) Intravenous amino acid therapy for kidney protection in cardiac surgery patients: a pilot randomized controlled trial. J Thorac Cardiovasc Surg 157:2356\u20132366. https:\/\/doi.org\/10.1016\/j.jtcvs.2018.11.097","journal-title":"J Thorac Cardiovasc Surg"},{"key":"8437_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00134-017-4732-1","volume":"43","author":"JA Kellum","year":"2017","unstructured":"Kellum JA, Zarbock A, Nadim MK (2017) What endpoints should be used for clinical studies in acute kidney injury? Intensive Care Med 43:901\u2013903. https:\/\/doi.org\/10.1007\/s00134-017-4732-1","journal-title":"Intensive Care Med"},{"key":"8437_CR10","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s00134-024-07560-y","volume":"50","author":"A Zarbock","year":"2024","unstructured":"Zarbock A, Forni LG, Koyner JL, Bell S, Reis T, Meersch M et al (2024) Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement. Intensive Care Med 50:1426\u20131437. https:\/\/doi.org\/10.1007\/s00134-024-07560-y","journal-title":"Intensive Care Med"},{"key":"8437_CR11","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1681\/ASN.2021121605","volume":"33","author":"M Legrand","year":"2022","unstructured":"Legrand M, Bagshaw SM, Koyner JL, Schulman IH, Mathis MR, Bernholz J et al (2022) Optimizing the design and analysis of future AKI trials. J Am Soc Nephrol 33:1459\u20131470. https:\/\/doi.org\/10.1681\/ASN.2021121605","journal-title":"J Am Soc Nephrol"},{"key":"8437_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrneph.2013.232","volume":"10","author":"JR Prowle","year":"2014","unstructured":"Prowle JR, Kirwan CJ, Bellomo R (2014) Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 10:37\u201347. https:\/\/doi.org\/10.1038\/nrneph.2013.232","journal-title":"Nat Rev Nephrol"},{"key":"8437_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13054-016-1218-4","volume":"20","author":"S De Rosa","year":"2016","unstructured":"De Rosa S, Samoni S, Ronco C (2016) Creatinine-based definitions: from baseline creatinine to serum creatinine adjustment in intensive care. Crit Care 20:69. https:\/\/doi.org\/10.1186\/s13054-016-1218-4","journal-title":"Crit Care"},{"key":"8437_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s13054-016-1539-3","volume":"20","author":"HM Al-Dorzi","year":"2016","unstructured":"Al-Dorzi HM, Albarrak A, Ferwana M, Murad MH, Arabi YM (2016) Lower versus higher dose of enteral caloric intake in adult critically ill patients: a systematic review and meta-analysis. Crit Care 20:358. https:\/\/doi.org\/10.1186\/s13054-016-1539-3","journal-title":"Crit Care"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08437-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08437-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08437-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:36:57Z","timestamp":1780043817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-026-08437-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["8437"],"URL":"https:\/\/doi.org\/10.1007\/s00134-026-08437-y","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SDR has received speaker fees from Aferetica, Estor, Toray, Vantive, and Alexion. All other authors declare no conflicts of interest. ML is supported by grant R01-GM151494-01 and R01DK139484-01 from the NIH. Dr. Legrand reports consulting fees from Viatris, Pharmazz Inc, Vantive, Idorsia, Estor and OceaneX. MJ has received grants from Baxter\/Vantive and Fresenius, consulting fees from Baxter\/Vantive, AmPharma, Biomerieux, SphingoTec and Novartis as well as lecture fees from Baxter, Biomerieux and AOP and is a board member of the International Society of Critical Care Nephrology (ISCCN).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}